Clinuvel Pharmaceuticals (UR9) Revenue
Clinuvel Pharmaceuticals Revenue
Clinuvel Pharmaceuticals had a revenue of 57.09M in the quarter ending Jun 30, 2026, with 54.60%. This bring the company's revenue in the last twelve months to 94.02M, Decreased 2.37%. In the fiscal year ending Jun 30, 2026, Clinuvel Pharmaceuticals had annual revenue of 94.02M with -1.05% growth.
- Revenue (ttm)
- 94.02M
- Revenue Growth
- -3.96%
- P/S Ratio
- 2.25
- Revenue/Employee
- CHF 5,876,500
- Employees
- 16
- Market Cap
- CHF 211.48M
Revenue Chart
Clinuvel Pharmaceuticals Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2026 | 94.02M | -993.57K | -1.05% |
| Jun 30, 2025 | 95.02M | 6.84M | 7.76% |
| Jun 30, 2024 | 88.18M | 9.86M | 12.59% |
| Jun 30, 2023 | 78.32M | 12.60M | 19.17% |
| Jun 30, 2022 | 65.72M | 17.75M | 36.99% |
| Jun 30, 2021 | 47.98M | 15.41M | 47.32% |
| Jun 30, 2020 | 32.57M | 1.52M | 4.89% |
| Jun 30, 2019 | 31.05M | 5.56M | 21.82% |
| Jun 30, 2018 | 25.49M | 8.72M | 52.01% |
| Jun 30, 2017 | 16.77M | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.